Evidence map›Paper›PMID 24861560›Full record

SynthesisJAMA internal medicine2014

Stability of end-of-life preferences: a systematic review of the evidence.

Catherine L Auriemma, Christina A Nguyen, Rachel Bronheim, Saida Kent, Shrivatsa Nadiger, Dustin Pardo, Scott D Halpern

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in JAMA internal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04239209 (The Effect of Intensivist Communication on Prognosis Interpretation by Family Members of Patients at High Risk for Intensive Care Unit Admission), which is not on this map. Cited by 101 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04239209 nacompletednot on this mapstarted 2019, after this paper: background citation

The Effect of Intensivist Communication on Prognosis Interpretation by Family Members of Patients at High Risk for Intensive Care Unit Admission: A Randomized Trial

TypeinterventionalSponsorJohns Hopkins UniversityRan2019 to 2019Enrolled302ConditionsCritical IllnessArmsIndirect - other patients, Indirect - physiology, Redirection, Direct communication
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial.Medical decision making : an international journal of the Society for Medical Decision Making · 2022
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Observational
  15. Artificial intelligence and medical futility.BMC medical informatics and decision making · 2026
    Review
  16. Article
  17. Article
  18. Advanced cancer patients' knowledge and opinions regarding the French law on advance directives: a multicenter cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Catherine L AuriemmaUniversity of Pennsylvania Perelman School of Medicine, Philadelphia2Fostering Improvement in End-of-Life Decision Science (FIELDS) Program, University of Pennsylvania, Philadelphia.
Christina A NguyenFostering Improvement in End-of-Life Decision Science (FIELDS) Program, University of Pennsylvania, Philadelphia3Harvard College, Harvard University, Cambridge, Massachusetts4Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman.
Rachel BronheimLeonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia5Woodrow Wilson School of Public and International Affairs, Princeton University, Princeton, New Jersey.
Saida KentFostering Improvement in End-of-Life Decision Science (FIELDS) Program, University of Pennsylvania, Philadelphia.
Shrivatsa NadigerDepartment of Medicine, Presbyterian Hospital, Philadelphia, Pennsylvania.
Dustin PardoDepartment of Medicine, Einstein/Montefiore Medical Center, New York, New York.
Scott D HalpernFostering Improvement in End-of-Life Decision Science (FIELDS) Program, University of Pennsylvania, Philadelphia4Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia8Division of Pulmonary, Aller.

Funding

Training in Critical Care Health Policy ResearchT32HL098054 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Scott D Halpern · 2010 to 2026
$8.2M
NHLBI NIH HHS T32 HL098054
6 · The paper itself

Abstract

importancePolicies and practices that promote advance care planning and advance directive completion implicitly assume that patients' choices for end-of-life (EOL) care are stable over time, even with changes in health status.

objectiveTo systematically evaluate the evidence on the stability of EOL preferences over time and with changes in health status. EVIDENCE REVIEW: We searched for longitudinal studies of patients' preferences for EOL care in PubMed, EMBASE, and using citation review. Studies restricted to preferences regarding the place of care at the EOL were excluded.

findingsA total of 296 articles were assessed for eligibility, and 59 met inclusion criteria. Twenty-four articles had sufficient data to extract or calculate the percentage of individuals with stable preferences or the percentage of total preferences that were stable over time. In 17 studies (71%) more than 70% of patients' preferences for EOL care were stable over time. Preference stability was generally greater among inpatients and seriously ill outpatients than among older adults without serious illnesses (P < .002). Patients with higher education and who had engaged in advance care planning had greater preference stability, and preferences to forgo therapies were generally more stable than preferences to receive therapies. Among 9 of the 24 studies (38%) assessing changes in health status, no consistent relationship with preference changes was identified. CONCLUSIONS AND RELEVANCE: Considerable variability among studies in the methods of preference assessment, the time between assessments, and the definitions of stability preclude meta-analytic estimates of the stability of patients' preferences and the factors influencing these preferences. Although more seriously ill patients and those who engage in advance care planning most commonly have stable preferences for future treatments, further research in real-world settings is needed to confirm the utility of advance care plans for future decision making.

Indexed as

Patient PreferenceAdvance DirectivesHumansTerminal Care

Identifiers

PMID24861560
PMCPMC8243894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.